Actual Medicinal Product (AMP) Depakote 500mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Valproate-containing medicines must always be dispensed in the manufacturer’s original full pack unless there are exceptional circumstances. The Patient Information Leaflet should be provided.
No stability data in MCAs available.
- Provenance
-
This recommendation is based on the product Depakote 500mg gastro-resistant tablets (SANOFI).
- Generic
- Valproic acid
- Formulation
- Valproic acid 500mg gastro-resistant tablets
-
Valproic acid
-
Valproic acid 500mg gastro-resistant tablets
-
Depakote 500mg gastro-resistant tablets (Mawdsley-Brooks & Company Ltd)
-
-